Stockscreener 앱 받기
1.98
1.00%
-0.02
시장 영업 전:
1.99
0.01
+0.51%
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Caribou Biosciences Inc.’s volatility index tracking explainedMarket Movement Recap & Safe Entry Zone Identification - Newser
Quantitative breakdown of Caribou Biosciences Inc. recent moveJuly 2025 Volume & High Accuracy Swing Entry Alerts - Newser
News impact scoring models applied to Caribou Biosciences Inc.2025 Volatility Report & Daily Oversold Bounce Ideas - Newser
Historical volatility pattern of Caribou Biosciences Inc. visualizedGDP Growth & Technical Entry and Exit Alerts - Newser
Why Caribou Biosciences Inc. is moving todayJuly 2025 Recap & Free Technical Pattern Based Buy Signals - Newser
Published on: 2025-08-27 13:44:57 - Newser
August 2025's Top Penny Stocks With Growth Potential - Yahoo Finance
What the charts say about Caribou Biosciences Inc. todayWeekly Gains Report & Free Community Consensus Stock Picks - Newser
Published on: 2025-08-27 10:50:07 - Newser
Caribou Biosciences Inc. stock prediction for this weekJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - Newser
Will Caribou Biosciences Inc. benefit from green energy policies2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - sundaytimes.kr
Is a relief rally coming for Caribou Biosciences Inc. holdersTrade Entry Summary & Low Volatility Stock Suggestions - Newser
Can Caribou Biosciences Inc. Overcome Bearish Sentiment getLinesFromResByArray error: size == 0 - newsyoung.net
Long term hold vs stop loss in Caribou Biosciences Inc.Stop Loss & Accurate Trade Setup Notifications - Newser
Evercore ISI Initiates Coverage of Caribou Biosciences with Hold Rating and $1.00 Price Target - AInvest
Published on: 2025-08-26 13:57:11 - Newser
Published on: 2025-08-26 09:17:56 - Newser
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference - The Manila Times
Is now a turning point for Caribou Biosciences Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Sentiment Watch: What are the future prospects of Caribou Biosciences Inc.2025 Pullback Review & Verified Chart Pattern Trade Signals - sundaytimes.kr
Aug Rallies: How does Caribou Biosciences Inc. score in quality rankingsJuly 2025 Decliners & Free High Accuracy Swing Entry Alerts - theviewers.co.kr
Is Caribou Biosciences Inc. forming a bottoming baseChart Signals & Stepwise Swing Trade Plans - Newser
Chart Analysts Warn of Resistance Near Caribou Biosciences Inc. PriceJuly 2025 Patterns & Free Low Drawdown Momentum Trade Ideas - beatles.ru
Top chart patterns to watch in Caribou Biosciences Inc.Global Markets & Short-Term High Return Ideas - Newser
Caribou Biosciences reports Q2 EPS (35c), one estimate (42c) - MSN
Momentum Screeners Rank Caribou Biosciences, Inc. in Top 5 TodayJuly 2025 Update & Low Risk Growth Stock Ideas - 더경남뉴스
Leading vs lagging indicators on Caribou Biosciences Inc. performanceQuarterly Profit Summary & Expert Verified Movement Alerts - Newser
Caribou Biosciences Inc. Pullback Analyzed — Is It Time to Exit2025 Sector Review & Short-Term High Return Ideas - kangso.co.kr
Caribou Biosciences Inc.’s Price Action Aligns with Quant SignalsWeekly Trade Review & AI Powered Buy/Sell Recommendations - beatles.ru
How does Caribou Biosciences Inc. score in quality rankingsCPI Data & Expert Verified Movement Alerts - 선데이타임즈
Using economic indicators to assess Caribou Biosciences Inc. potentialJuly 2025 Institutional & Stepwise Swing Trade Plans - Newser
Using data tools to time your Caribou Biosciences Inc. exit2025 Trade Ideas & Scalable Portfolio Growth Ideas - Newser
Is Caribou Biosciences Inc. Forming a Bottom PatternGlobal Markets & Reliable Entry Point Alerts - metal.it
What’s the recovery path for long term holders of Caribou Biosciences Inc.Analyst Upgrade & Scalable Portfolio Growth Methods - Newser
Truist Financial analyst assigns Buy rating to Caribou Biosciences with $3.50 price target. - AInvest
RBC Capital Maintains Buy Rating for Caribou Biosciences with $10 Price Target - AInvest
Caribou Biosciences: Strong Clinical Progress and Financial Health Justify Buy Rating with $3.00 Target - AInvest
Caribou Biosciences: Promising Clinical Progress and Strong Financial Position Justify Buy Rating - TipRanks
Caribou Biosciences Reports Wider Q2 Loss Amid Increased R&D Spending - AInvest
Caribou Biosciences Reports Increased Losses Amid R&D Efforts - TipRanks
Navigating the Storm: Caribou Biosciences' Strategic Rebalancing and the Road to Gene-Editing Dominance - AInvest
Caribou Biosciences earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Caribou Biosciences Q2 2025: $184mln cash, H2 2027 funding, CB-010 & CB-011 data in H2 2025. - AInvest
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Is Caribou Biosciences Inc. Forming a Consolidation BaseTrade Setups With Clear Risk Limits Highlighted - beatles.ru
0.98%
8.06%
자본화:
|
볼륨(24시간):